(MedPage Today) -- Among patients with extensively drug-resistant tuberculosis, adding linezolid (Zyvox) to standard therapies appears to improve treatment response, but with a high rate of adverse events, a phase IIb trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment